Adenna Inc. announces it has reached a licensing agreement with Maxxim Medical to market and sell the PURITY™ glove under the Adenna label. This new glove is manufactured with INTACTA™, proprietary performance polymers developed by the Dow Chemical Company.

This glove eliminates the life-threatening Type I allergic reaction to natural rubber latex, and dramatically reduces the risk of Type IV reactions associated with chemical crosslinkers and accelerators, commonly used in manufacturing of latex and other synthetic gloves. Unlike other non-latex gloves, Adenna’s PURITY™ glove provides excellent fit, feel, and tear resistance. It also has excellent “memory” which allows it to retain its original shape when stretched and relaxed.

Adenna will preview this new product at the annual HIDA, Healthcare Distribution Conference and Expo, which will be held in San Diego, December 6-8, 2001. Maxwell Lee, President of Adenna Inc, stated, “As concerns over latex sensitivities grow, we believe that PURITY™ will become the industry standard as the best alternative available. Through our partnership with Maxxim Medical and the technology advancement of Dow Chemical, Adenna is able to remain at the forefront of providing cost-effective, high quality, latex-free solutions. We look forward to introducing this new product to our nationwide network of Distributors/ Partners at the upcoming HIDA event.” Maxxim Medical develops, manufactures, and sells a diversified range of specialty medical products for operating rooms, surgery centers, cardiac catheterization labs and interventional radiology centers.

The Dow Chemical Company is a global science and technology based company that develops and manufactures a portfolio of chemical, plastic, and agricultural products.